12.3 Multiple Sclerosis, Guillain-Barré Syndrome & Amyotrophic Lateral Sclerosis

12.3 Multiple Sclerosis, Guillain-Barré Syndrome & Amyotrophic Lateral Sclerosis

[!NOTE] DHA Licensure Focus: The DHA Physiotherapist exam rigorously assesses differential diagnosis and clinical exercise prescription across adult neurodegenerative and demyelinating disorders. Candidates must recognize the pathophysiology and clinical hallmarks separating central demyelination (Multiple Sclerosis) from peripheral autoimmune neuropathy (Guillain-Barré Syndrome) and mixed motor neuron disease (Amyotrophic Lateral Sclerosis). Key testing topics include managing heat sensitivity (Uhthoff's phenomenon), identifying acute respiratory crises in GBS, avoiding overwork weakness in denervated motor units, and prescribing safe, submaximal exercise parameters.

Neurological rehabilitation requires deep insight into the distinct cellular pathologies and functional trajectories of chronic and acute neuromuscular diseases. Designing effective, safe physical therapy programs hinges on understanding whether a disease process is reversible, relapsing, or relentlessly progressive, and respecting biological boundaries that protect weakened neuromuscular units from exercise-induced damage.

---

1. Multiple Sclerosis (MS): CNS Autoimmune Demyelination

Multiple Sclerosis (MS) is a chronic, immune-mediated inflammatory disease of the Central Nervous System (CNS). Autoreactive T-lymphocytes cross the blood-brain barrier, triggering an inflammatory cascade featuring perivascular cuffing, microglial activation, and destruction of oligodendrocytes and the myelin sheath. Over time, chronic demyelination leads to reactive astrogliosis (forming hard, fibrotic glial "plaques" or scleroses) and irreversible secondary axonal transection.

+-----------------------------------------------------------------------------------+
|                     Multiple Sclerosis Disease Phenotypes                         |
+-----------------------------------------------------------------------------------+
| 1. Relapsing-Remitting MS (RRMS) - ~85% of Cases at Onset:                        |
|    - Clearly defined relapses/exacerbations with acute neurological worsening     |
|    - Followed by partial or complete recovery (remission) with stable function    |
|    - No disease progression between attacks                                       |
+-----------------------------------------------------------------------------------+
| 2. Secondary Progressive MS (SPMS):                                               |
|    - Originates as RRMS, followed by transition to steady progressive neurological |
|      decline with or without superimposed relapses and minor remissions           |
|    - Most RRMS patients transition to SPMS after 15 to 25 years without treatment |
+-----------------------------------------------------------------------------------+
| 3. Primary Progressive MS (PPMS) - ~10-15% of Cases:                              |
|    - Continuous, gradual neurological decline from disease onset                  |
|    - Absence of distinct acute relapses or remissions; early severe spinal cord   |
|      involvement (progressive spastic paraparesis, neurogenic bladder)            |
+-----------------------------------------------------------------------------------+

Hallmark Clinical Manifestations

• Charcot's Neurological Triad: A classic historical triad indicating demyelinating plaques within the brainstem and cerebellar peduncles:
  1. Intention Tremor: Tremor that increases in amplitude at the terminal phase of purposeful, visually guided movement (e.g., finger-to-nose testing).
  2. Nystagmus: Involuntary, rhythmic oscillating eye movements during lateral or vertical gaze.
  3. Scanning Speech: Slow, staccato, monotonic dysarthria with unnatural pauses between individual syllables.
• Lhermitte's Sign: A transient, intense electric-shock sensation that shoots down the spine and radiates into the limbs elicited by active or passive cervical flexion, indicative of demyelinating plaques in the posterior columns of the cervical spinal cord.
• Optic Neuritis: Acute, painful, typically unilateral loss of visual acuity accompanied by central scotoma and an afferent pupillary defect (Marcus Gunn pupil).

Uhthoff's Phenomenon & Thermal Dysregulation

Uhthoff's phenomenon refers to the temporary, reversible worsening of pre-existing neurological symptoms (most commonly visual blurring, profound fatigue, ataxia, and muscular weakness) triggered by an elevation in core body temperature.

• Biophysical Mechanism: Demyelinated axons have an extremely narrow safety factor for action potential propagation. A rise in core temperature of as little as 0.5°C (from physical exertion, environmental heat, hot showers, or fever) accelerates the inactivation kinetics of voltage-gated sodium channels, causing a transient functional conduction block along partially demyelinated fibers. When the body cools back down, conduction is fully restored within hours.
• Clinical Physical Therapy Protocol for Uhthoff's Phenomenon:
  • Environmental Control: Conduct exercise sessions in climate-controlled gymnasiums maintained at 18°C to 20°C (64°F to 68°F).
  • Pre-Cooling & Concurrent Cooling: Implement active cooling modalities, including wearable cold-water or iced cooling vests, cold gel neck wraps, and pre-exercise ingestion of ice slurry / iced drinks.
  • Aquatic Therapy Parameters: Therapeutic pools must be maintained between 28°C and 30°C (82°F–86°F); warm hydrotherapy pools (>32°C) are strictly contraindicated.

MS Fatigue Management & The "4 Ps"

Fatigue is the single most debilitating symptom reported by over 80% of MS patients. Unlike ordinary muscular tiredness, MS fatigue is a central neurogenic lassitude present even at rest.

• The "4 Ps" of Energy Conservation:
  1. Pacing: Interspersing physical exertion with planned, frequent rest intervals. Performing exercise in interval bouts (e.g., 3 minutes of cycling followed by 2 minutes of rest) rather than continuous exhaustive loading.
  2. Planning: Scheduling physically demanding tasks during peak energy windows (typically the cool morning hours) and structuring the weekly calendar to balance high- and low-energy days.
  3. Prioritizing: Distinguishing essential personal activities from discretionary tasks, delegating heavy household chores.
  4. Positioning: Modifying posture and ergonomics to minimize unnecessary metabolic energy expenditure (e.g., seated cooking, seated showering, using slide boards for transfers).
• Exercise Prescription: Moderate-intensity aerobic training (50% to 70% VO2max or HRmax, Borg RPE 11–13) and progressive resistance training targeting antigravity extensor muscles (2–3 days/week). Exercise should terminate well short of complete muscular exhaustion.

---

2. Guillain-Barré Syndrome (GBS): Acute Peripheral Demyelination

Guillain-Barré Syndrome (GBS) is an acute, post-infectious, autoimmune polyradiculoneuropathy affecting the Peripheral Nervous System (PNS). The most common subtype in North America and Europe is Acute Inflammatory Demyelinating Polyradiculoneuropathy (AIDP).

ANTECEDENT INFECTION (Campylobacter jejuni in >30%, CMV, EBV, Mycoplasma, Zika)
                                      │
                                      ▼
MOLECULAR MIMICRY: Microbial lipooligosaccharides share antigens with human gangliosides
                                      │
                                      ▼
AUTOANTIBODIES BIND TO SCHWANN CELL MEMBRANES & NODES OF RANVIER IN PNS
                                      │
                                      ▼
Complement Activation & Macrophage Infiltration ───> PARCHMENT STRIPPING OF PNS MYELIN
                                      │
                                      ▼
RAPID CONDUCTION BLOCK & AXONAL DROPOUT
- Rapid, Symmetrical Ascending Flaccid Paralysis (Lower Limbs ──> Trunk ──> Upper Limbs)
- Generalized Areflexia (Absent DTRs: 0/4)
- Autonomic Instability (Labile BP, Tachyarrhythmias)
- Neuromuscular Diaphragmatic Respiratory Failure (25-30% of Patients)

Cardinal Clinical Presentation

• Ascending Symmetrical Weakness: Flaccid weakness begins distally in the lower extremities (toes, feet) and ascends rapidly over hours to days to involve the proximal thighs, pelvic girdle, trunk, upper extremities, and cranial nerves (especially CN VII, facial diplegia in 50%).
• Generalized Areflexia: Universal absence (0/4) or severe diminution (1+/4) of deep tendon reflexes in affected limbs is an absolute diagnostic prerequisite.
• Sensory Symptoms: Distal paresthesias, "pins-and-needles," and stocking-glove sensory dullness. However, motor paralysis vastly outweighs sensory loss.
• Autonomic Instability: Fluctuating, labile blood pressure (severe hypertension alternating with orthostatic hypotension), cardiac arrhythmias, profuse diaphoresis, and neurogenic urinary retention.

Acute Phase Respiratory Red Flags: The "20/30 Rule"

Diaphragmatic and intercostal muscle denervation occurs in approximately 25% to 30% of patients, leading to acute hypercapnic respiratory arrest. Physical therapists working in acute inpatient wards must perform continuous bedside monitoring:

+-----------------------------------------------------------------------------------+
|                Bedside Respiratory Red Flags in Acute GBS                         |
+-----------------------------------------------------------------------------------+
| 1. Forced Vital Capacity (FVC):                                                   |
|    - Normal Adult: 50-60 mL/kg                                                    |
|    - Impending Failure: FVC <15 to 20 mL/kg (or absolute volume <1.0 Liter)       |
+-----------------------------------------------------------------------------------+
| 2. Negative Inspiratory Force (NIF) / Maximal Inspiratory Pressure (MIP):         |
|    - Normal Adult: -80 to -120 cmH2O                                              |
|    - Impending Failure: NIF drops closer to zero than -20 to -30 cmH2O (e.g., -18)|
+-----------------------------------------------------------------------------------+
| 3. Single-Breath Counting Test:                                                   |
|    - Instruct patient to take a maximum inspiration and count aloud at 2 Hz       |
|    - Normal: Counts to 30-40+ on single breath                                    |
|    - Impending Failure: Unable to count past 15 to 20 on a single breath           |
+-----------------------------------------------------------------------------------+
| *** CRITICAL ACTION: If FVC <20 mL/kg or NIF <-30 cmH2O, notify physician         |
|     immediately for urgent ICU transfer and elective endotracheal intubation! *** |
+-----------------------------------------------------------------------------------+

Phase-Specific Physical Therapy in GBS

1. Acute Phase (Progression to Nadir, Days 1–14):

   • Disease Status: Rapidly worsening paralysis reaching a nadir (maximum weakness) within 2 to 4 weeks, followed by a plateau.
   • PT Role: Prevent secondary immobility complications while avoiding neuromuscular fatigue.
   • Interventions: Aggressive airway clearance (suctioning, assisted coughing, postural drainage), frequent turning every 2 hours to prevent decubitus ulcers, gentle passive ROM (PROM) to maintain joint capsule compliance, and neutral resting splints (ankle-foot orthoses) to prevent Achilles contractures and foot drop. Avoid aggressive stretching beyond pain thresholds, which can trigger severe neuropathic pain.

2. Recovery / Remyelination Phase:

   • Disease Status: Schwann cells initiate remyelination and axonal regeneration occurs at approximately 1 mm/day. Functional recovery is prolonged (months to years).
   • The Overwork Weakness Hazard: Overworking partially denervated, regenerating motor units can cause permanent axonal necrosis! Immature, newly remyelinated axons are vulnerable to metabolic burnout.
   • Exercise Guidelines:
     • Low-resistance, non-fatiguing, submaximal active-assisted to active exercises.
     • Strictly avoid heavy eccentric resistance loading!
     • Use short exercise bouts with frequent rest breaks.
     • The 24-Hour Rule: If the patient experiences marked muscle soreness, persistent fatigue, or measurable weakness lasting more than 24 hours post-session, the exercise volume and intensity were excessive and must be immediately reduced.

---

3. Amyotrophic Lateral Sclerosis (ALS / Motor Neuron Disease)

Amyotrophic Lateral Sclerosis (ALS) is a fatal, rapidly progressive neurodegenerative disorder characterized by the selective degeneration of both Upper Motor Neurons (UMNs) and Lower Motor Neurons (LMNs).

                    AMYOTROPHIC LATERAL SCLEROSIS (ALS)
                                     │
        ┌────────────────────────────┴────────────────────────────┐
        ▼                                                         ▼
UPPER MOTOR NEURON (UMN) LOSS             LOWER MOTOR NEURON (LMN) LOSS
(Precentral Gyrus & Corticospinal Tract)  (Brainstem Nuclei & Anterior Horn Cells)
        │                                                         │
        ▼                                                         ▼
- Spasticity & Hypertonia                 - Flaccid Weakness & Paralysis
- Pathological Hyperreflexia (3+/4+)      - Severe Muscle Atrophy (Amyotrophy)
- Babinski Sign & Clonus                  - Spontaneous Fasciculations
- Hoffman's Sign                          - Hyporeflexia / Absent Reflexes
- Pseudobulbar Affect (Lability)          - Painful Muscle Cramps
        │                                                         │
        └────────────────────────────┬────────────────────────────┘
                                     │
                                     ▼
               THE PATHOGNOMONIC CLINICAL HALLMARK OF ALS:
      Coexistence of UMN and LMN Signs Simultaneously within the SAME Limb!
      (e.g., Profoundly Atrophic, Wasted Hand Muscles exhibiting Brisk 3+ Reflexes)

Sparing in ALS: What Remains Intact

Crucially, ALS selectively targets somatic motor neurons while characteristically sparing:

• Extraocular Motor Neurons (Cranial nerves III, IV, VI): Eye movements remain preserved even in late-stage "locked-in" states.
• Onuf's Nucleus: Somatic motor neurons in the S2–S4 anterior horns supplying the external urethral and anal sphincters remain preserved, maintaining continence.
• Sensory Pathways: Light touch, pinprick, and proprioception remain intact.

Clinical Presentation: Limb-Onset vs. Bulbar-Onset

• Limb-Onset ALS (~70%): Asymmetric distal weakness, such as painless foot drop (tripping over curbs) or progressive hand intrinsic weakness (dropping coffee cups, difficulty turning keys).
• Bulbar-Onset ALS (~30%): Degeneration of motor nuclei of CN IX, X, and XII, presenting with progressive dysarthria, dysphagia, tongue atrophy with prominent continuous fasciculations, and vocal cord paresis. Associated with a faster progression rate.

Physical Therapy Management & Exercise Boundaries in ALS

Physical therapy in ALS is restorative in early stages, purely compensatory in middle stages, and supportive/palliative in late stages.

+-----------------------------------------------------------------------------------+
|                    Physical Therapy Exercise Guidelines in ALS                    |
+-----------------------------------------------------------------------------------+
| 1. Muscles with MMT Grade ≥3+/5 (Antigravity with Resistance):                    |
|    - Safe for moderate, submaximal resistance and concentric aerobic exercise      |
|    - Intensity: Moderate (RPE 11-13 on Borg 6-20 scale)                          |
|    - Aerobic: Walking, stationary cycling, low-impact aquatic therapy             |
+-----------------------------------------------------------------------------------+
| 2. Muscles with MMT Grade <3/5 (Cannot Move Against Full Gravity):                |
|    - *** ABSOLUTE CONTRAINDICATION FOR RESISTANCE TRAINING ***                    |
|    - Heavily denervated muscle fibers undergo irreversible overwork necrosis      |
|    - Use active-assisted range of motion and functional compensatory orthoses     |
+-----------------------------------------------------------------------------------+
| 3. Movement Types:                                                                |
|    - Strictly avoid heavy eccentric muscle loading (downhill walking, heavy leg   |
|      press negatives) which produces severe sarcolemmal damage                    |
+-----------------------------------------------------------------------------------+

Supportive Devices & Respiratory Milestones

• Cervical Extensor Weakness ("Head Drop"): Progressive denervation of cervical extensors produces painful neck drop; managed with customized cervical orthoses, such as the Headmaster Collar or molded Aspen collar.
• Lower Extremity Foot Drop: Prescribe lightweight custom Ankle-Foot Orthoses (AFOs) to maintain toe clearance, normalize gait kinematics, and prevent falls.
• Power Mobility: Early prescription of a power wheelchair equipped with power tilt-in-space, recline, and elevating leg rests.
• Non-Invasive Ventilation (NIV / BiPAP): Respiratory failure secondary to diaphragmatic atrophy is the primary cause of mortality in ALS. Initiation of BiPAP is indicated when Forced Vital Capacity drops below 50% of predicted or Maximal Inspiratory Pressure falls below -60 cmH2O. NIV extends survival by months and dramatically improves quality of life.

---

4. Comprehensive Differential Diagnostic Matrix

---

5. Clinical Scenarios & DHA Exam Traps

Clinical Scenario: Uhthoff's Phenomenon in the Outpatient Gym

A 32-year-old female with relapsing-remitting multiple sclerosis (RRMS) presents for gait training. The outpatient gym air conditioning is malfunctioning, and the room temperature is 26°C (79°F). After 12 minutes of moderate treadmill walking, the patient develops profound bilateral leg heaviness, blurred vision, and unsteady gait. She panics, believing she is suffering an acute MS relapse.

• Clinical Reasoning: This is a classic presentation of Uhthoff's phenomenon (pseudo-exacerbation) triggered by elevated core body temperature causing a conduction block in demyelinated optic and corticospinal pathways.
• Immediate Management: The therapist immediately ceases treadmill exercise, escorts the patient to a climate-controlled room (19°C), applies cold towels to her neck, and provides iced water to drink. Within 45 minutes, her visual acuity and leg strength return to baseline. The therapist educates the patient on pre-cooling and scheduling therapy during cooler morning hours.

DHA Exam Traps to Avoid

• Trap 1: Misinterpreting GBS as an Upper Motor Neuron Lesion: DHA exam questions often describe a patient with rapid leg weakness following a diarrheal illness. If the question asks about reflexes, candidates mistakenly select hyperreflexia because the weakness is bilateral. GBS is a pure Lower Motor Neuron / peripheral nerve lesion that produces generalized AREFLEXIA (0/4).
• Trap 2: Overwork Weakness in ALS and GBS: Questions frequently ask whether a patient with ALS who has 2/5 anterior tibialis strength should perform high-resistance eccentric cuff weight exercises to regain strength. The answer is strictly NO. Resistance training in denervated muscles scoring below 3/5 causes permanent myofibrillar necrosis and accelerated weakness. AFO prescription is the correct answer.
• Trap 3: Uhthoff's Phenomenon vs. True MS Relapse: A true MS relapse represents active immune plaque formation with new gadolinium enhancement on MRI that develops over days and persists for more than 24 to 48 hours. Uhthoff's phenomenon is a transient physical conduction block that resolves completely within minutes to hours of cooling.